RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - NANO E MICROPARTICELLE INNOVATIVE PER OTTIMIZZARE LA BIODISPONIBILITA' DEI FARMACI
• 2 - NANO/MICROTECNOLOGIE PER MODULARE LA DISPONIBILITA' BIOLOGICA DI FARMACI CON SOLUBILITA' E PERMEABILITA' CRITICHE
• 3 - Idrogel per il rilascio modificato di farmaci: sintesi, caratterizzazione, applicazioni
• 4 - Sviluppo di nanocompositi ibridi "host-guest" per il rilascio modificato di farmaci mediante approcci innovativi di caratterizzazione sperimentale a livello molecolare
• 5 - Nanovettori nella terapia anticancro
• 6 - Biomateriali Inorganico-Polimerici per il Rilascio Controllato di Molecole Bioattive
• 7 - Materiali microstrutturati prodotti mediante processi innovativi assistiti da fluidi supercritici
• 8 - Sistemi colloidali e chimici avanzati per il trattamento di patologie neurodegenerative del SNC.
• 9 - METODOLOGIE ANALITICHE AVANZATE NELLA RICERCA E SVILUPPO DI FARMACI
• 10 - Antidepressivi e meccanismi molecolari di plasticità neuronale

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze chimiche
  • FARMACEUTICO TECNOLOGICO APPLICATIVO

Classificazione brevettuale

• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Lombardia

Bibliografia

1) Chien Y. W., Novel Drug Delivery System, 2nd Ed. Marcell Dekker Pub. New York, (1992)
2)Sayani A.P, Chien Y.W., Systemic delivery of peptides and proteins across absorptive mucosae, Crit. Rev. Ther. Drug Car. Syst.,13 (1, 2), 85-184 (1996)
3) Hussein A.A., Intranasal drug delivery, Advanced Drug Delivery Reviews, 29, 39-49 (1998)
4) Burstein N.L., Ophthalmic drug formulations, in: Clinical Ocular Pharmacology, 3rd Ed., J.D. Bartlett, and S.D. Jaanus Eds., Butterworth-Heinemann, Newton, MA, pp. 21-45, (1995)
5) Illum L., Chitosan and its use as a pharmaceutical excipient, Pharm. Res., 15 (9), 1326-1331 (1998)
6)Genta I., et al., Bioadesive microspheres for ophthalmic administration of acyclovir, J. Pharm. Pharmacol., 49, 737-742, (1997)
7) Witschi C. And Mrsny R.J., In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery, Pharm. Res., 16, 382-390, (1999)
8) Senel S., et al., Chitosan films and hydrogels of chlorexidine gluconate for oral mucosal delivery, Int. J. Pharm.,193, 197-203, (2000)
9) Lehr C.M., et al., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm., 78, 43-48, (1992)
10) Henriksen I., et al., Bioadhesion of hydrated chitosans: an in vitro and in vivo study, Int. J. Pharm., 145, 231-240, (1996)
11) Ferrari F., et al., Characterization of rheological and mucoadesive properties of three grades of chitosan hydrochloride, Il Farmaco, 52, 493-497, (1997)
12) Bernkop-Schnurch A., Chitosan and its derivates: potential excipients for peroral peptide delivery system, Int. J. Pharm., 194, 1-13, (2000)
13) Tengamnuay P., et al., Chitosan as nasal absorption enhancers of peptides: comparison between free amine chitosans and soluble salts, Int. J. Pharm., 197, 53-67, (2000)
14) Senel S., et al., Enhancing effects of chitosan on peptide drug delivery across buccal mucosa, Biomaterials, 21, 2067-2071, (2000)
15) Dodane V., et al., Effect of chitosan on epithelial permeability and structure, Int. J. Pharm., 182, 21-32, (1999)
16) Senel S., et al., Drug permeation enhancement via buccal route: possibilities and limitations, J. Controlled Rel., 72, 133-144, (2001)
17) Sandri, G., et al., Assessment of chitosan derivatives as buccal and vaginal penetration enhancers, Eur. J. Pharm. Sci, 21, 351-359, (2004)
18) Rossi, S., et al., Development of films and matrices based on chitosan and polyacrylic acid for vaginal delivery of acyclovir, STP Pharma Sci., 13, 183-190, (2003)
19) Kotze A.F., et al., Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2), J. Control. Rel., 51, 35-46, (1998)
20) Hamman J.H., et al., Enhancement of paracellular drug trasport across mucosal epithelia by N-trimethyl chitosan chloride, STP Pharma Sci.,10 (1), 35-38, (2000)
21) Thanou M., et al., Mono-N-carboxymethil chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo, J. Pharm. Sci., 90 (1), 38-46, (2001)
22) Gavini E., et al., Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in vitro/ex vivo studies, J. Pharm. Pharmacol., 57, 287-294 (2005)
23) Hegge A.B., et al., Chitosan mucoadhesive microparticles for the nasal administration of Carbamazepine. Proceeding International Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Nuremberg, Germany, 15th -18th March 2004
24) Dalpiaz A., et al., Brain targeting of antiischemic agent by nasal administration of microparticles, 15th International Symposium on Microencapsulation, Parma, 2005
25) Sandri G., et al., Buccal penetration enhancement properties of N-trimethyl-chitosans: influence of quaternization degree on absorption of a high molecular weight molecule, Int. J. Pharm. in press.
26) Sandri G., et al., Mucoadhesive and penetration enhancement properties of three grades of hyaluronic acid using porcine buccal and vaginal tissue, Caco-2 cell lines, and rat jejunum, J. Pharm. Pharmacol., 56 (9), 1083-1090, (2004)
27) Di Colo G., et al., Effects of different N-trimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation, J. Pharm. Sci., 93, 2851-286, (2004)
28) Zambito Y., et al., Methyl-DEAE-dextran: a candidate biomaterial, Bio-Med. Mater. Engin., 14, 411-417, (2004)
29) Di Colo G., et al., Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin, Int. J. Pharm., 273, 37-44, (2004)
30) Bernkop-Schnürch A., et al., Thiolated chitosans. Eur. J. Pharm. Biopharm., 57, 9-17, (2004).
31) Dharma S.K., et al., A preliminary study of corneal penetration of 125I-labelled iodoxuridine liposome, Acta Ophthalmol. (Copenh.), 64, 298-301, (1986)
32) Schaeffer H. E., et al., Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux, Invest. Ophthalmol. Vis. Sci., 23, 530-533, (1982)
33) Al-Muhammed J., et al., In-vivo studies on dexamethasone sodium phosphate liposomes, J. Microencapsul., 13, 293-306, (1996).
34) Chetoni P., et al., Comparison of liposome-encapsulated acyclovir with acyclovir ointment:ocular pharmacokinetics in rabbits, J. Ocular Pharm., 20, 169-177, (2004).
35) Kawakami S., et al., Sustained ocular delivery of tilisol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes, J. Pharm. Pharmacol., 53, 157-161, (2001)
36) Saettone M.F., et al., Ocular bioadesive drug delivery systems, in: Drugs and Pharmaceutical Sciences, E. Mathiowitz, C.M. Lehr and D. Chickering Eds., Marcel Dekker Inc., pp 601-640, (1999)
37) Vasir JK, et al, Bioadhesive microspheres as controlled drug delivery system, Int J. Pharm., 255, 13-32, (2003)
38) Kockish S., et al., Polymeric microspheres for drug delivery to the oral cavity: an in vitro evaluation of mucoadhesive potential, J. Pharm. Sci., 92(8), 1614-1623, (2003)
39) Lin WJ., et al., Comparison of chitosan and gelation coated microparticles: prepared by hot-melt method. J. Microencapsul., 20(2), 169-177, (2003)
40) Prego C., et al., Transmucosal macromolecular drug delivery, J. Contr. Rel., 101, 151-162, (2005)
41) Peppas N.A., et al., Nanoscale tecnology of mucoadhesive interactions, Adv Drug Delivery Rev., 56, 1675-1687, (2004)
42) Rodriguez L., et al., Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing process, Int. J. Pharm., 183, 133-143, (1999)
43) Passerini N., et al., Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing, J. Contr. Rel., 88(2), 263-275, (2003)
44) Albertini B., et al., Effect of Aerosil on the properties of lipid controlled release microparticles, J. Contr. Rel., 100 (2), 233-246, (2004)
45) Fini A., et al., Ultrasound-compacted and spray-congealed indomethacin/polyethyleneglycol systems, Int J Pharm., 247(1-2), 11-22, (2002)
46) Passerini N., et al., Characterisation of carbamazepine-Gelucire 50/13 microparticles prepared by a spray congealing process using ultrasounds, J. Pharm. Sci, 91(3), 699-707, (2002)
47) Albertini B., et al., Evaluation of ultrasonic atomization as a new approach to prepare ionically cross-linked chitosan microparticles, J. Pharm. Pharmacol., accepted for publication
48) Rodriguez L., et al., Hot Air Coating Technique as a novel method to produce microparticles. Drug Dev. Ind. Pharm., 30(9), 913-923, (2004)
49) Giovannelli L., et al., Characterization of nifedipine microparticles prepared by hot air coating technique, Int. J. Pharm., 293, 225-234, (2005)

Parole Chiave

VIA BUCCALE; VIA NASALE E TARGETING CEREBRALE; VIA OFTALMICA; VIA VAGINALE; MUCOADESIONE; PROMOZIONE DI ASSORBIMENTO; SISTEMI MICRO-NANO PARTICELLARI; SISTEMI TERMO/PH SENSIBILI; VESCICOLE